GB0803004D0 - Genetic variation associated with coeliac disease - Google Patents

Genetic variation associated with coeliac disease

Info

Publication number
GB0803004D0
GB0803004D0 GB0803004A GB0803004A GB0803004D0 GB 0803004 D0 GB0803004 D0 GB 0803004D0 GB 0803004 A GB0803004 A GB 0803004A GB 0803004 A GB0803004 A GB 0803004A GB 0803004 D0 GB0803004 D0 GB 0803004D0
Authority
GB
United Kingdom
Prior art keywords
coeliac disease
genetic variation
variation associated
snps
polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0803004A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Priority to GB0803004A priority Critical patent/GB0803004D0/en
Publication of GB0803004D0 publication Critical patent/GB0803004D0/en
Priority to PCT/GB2009/000475 priority patent/WO2009103992A1/en
Ceased legal-status Critical Current

Links

Abstract

The present invention provides a method of diagnosing coeliac disease, said method comprising analysing a sample of nucleic acid from a human subject to determine the presence or absence of one or more single nucleic polymorphisms (SNPs) in one or more human chromosomal regions selected from the group consisting of Iq31, 2ql l-2ql2, 3p21, 3q25-3q26, 3q28, 6q25 and 12q24.
GB0803004A 2008-02-19 2008-02-19 Genetic variation associated with coeliac disease Ceased GB0803004D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0803004A GB0803004D0 (en) 2008-02-19 2008-02-19 Genetic variation associated with coeliac disease
PCT/GB2009/000475 WO2009103992A1 (en) 2008-02-19 2009-02-19 Genetic variation associated with coeliac disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0803004A GB0803004D0 (en) 2008-02-19 2008-02-19 Genetic variation associated with coeliac disease

Publications (1)

Publication Number Publication Date
GB0803004D0 true GB0803004D0 (en) 2008-03-26

Family

ID=39271924

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0803004A Ceased GB0803004D0 (en) 2008-02-19 2008-02-19 Genetic variation associated with coeliac disease

Country Status (2)

Country Link
GB (1) GB0803004D0 (en)
WO (1) WO2009103992A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010067381A1 (en) * 2008-12-12 2010-06-17 Decode Genetics Ehf Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction
WO2011088125A1 (en) * 2010-01-14 2011-07-21 The Board Of Trustees Of The Leland Stanford Junior University Mutations in the lnk gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023148A2 (en) * 2005-08-22 2007-03-01 Innogenetics N.V. Nucleic acid variants in the lbp gene associated with altered innate immunity
WO2007028795A1 (en) * 2005-09-09 2007-03-15 Innogenetics N.V. Nucleic acid variants in the masp-2 gene associated with altered innate immunity

Also Published As

Publication number Publication date
WO2009103992A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
Heyn et al. Distinct DNA methylomes of newborns and centenarians
WO2009117122A3 (en) Genetic analysis
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2009059318A3 (en) Genes and polymorphisms associated with amd
NZ596614A (en) Diagnosis and treatment of alzheimer's disease
WO2011038155A3 (en) Genetic analysis
WO2008115419A3 (en) Gene expression markers for prediction of patient response to chemotherapy
GEP20146107B (en) Method of identifying disease risk factors
IL201577A (en) Method for analysis of populations of microorganisms, combination primers and kits comprising the same for use in such methods and primers or primer sets for use in studying the effect of external factors on population of microorganisms
WO2010004591A3 (en) Genetic variants for breast cancer risk assessment
WO2010018601A3 (en) Genetic variants predictive of cancer risk
WO2009092035A3 (en) Methods and compositions for the analysis of biological molecules
EP3831954A3 (en) Methods and compositions of molecular profiling for disease diagnostics
GB2467704A (en) Methods of monitoring conditions by sequence analysis
WO2007146819A3 (en) Methods for identifying and using snp panels
WO2009062166A3 (en) Dna microarray based identification and mapping of balanced translocation breakpoints
DE502005008373D1 (en) POLYMORPHISMS IN NOD2 / CARD15 GEN
WO2008117314A3 (en) Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2008136996A3 (en) Polymorphisms in genes affecting ace-related disorders and uses thereof
WO2009149026A3 (en) Genomic approaches to fetal treatment and diagnosis
WO2008033427A3 (en) Compositions and methods for detection of lysosomal storage disease
WO2008132763A3 (en) Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
WO2012078288A3 (en) Methods of determining risk of adverse outcomes in acute myeloid leukemia
WO2010103292A3 (en) A genotyping tool for improving the prognostic and clinical management of ms patients

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)